Modafinil to Improve Fatiguability
Cancer-related fatigue (CRF) and cancer-related cognitive impairment (CRCI) are among the most commonly reported disabling symptoms experienced by patients with advanced cancer. However, there are currently limited evidence-based pharmacologic interventions available. The investigators will conduct a Vanguard Randomized Clinical Trial (RCT) to estimate the effect of modafinil in managing CRF and CRCI, and to test the feasibility of carrying out the study.
18 years of age or older with stage III or IV cancer diagnosis [+5]
Currently receiving or have received cytotoxic chemotherapy in the last 6 weeks [+35]